RFA
RFA is a medical procedure with 40 clinical trials. Currently 3 active trials ongoing. Historical success rate of 86.7%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
13 of 15 finished
13.3%
2 ended early
3
trials recruiting
40
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma
Caprini Score in Venous Surgery: a Prospective Cohort Study
Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA)
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma
Clinical Trials (40)
TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma
Caprini Score in Venous Surgery: a Prospective Cohort Study
Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA)
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma
Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)
Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique
Mechanochemical Ablation vs Thermal Ablation
A Randomized Trial of Contact Force in Atrial Flutter Ablation
Radiofrequency Ablation Combined With Melatonin in the Treatment of Stage IA NSCLC
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer
Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma
Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue
Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma
Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 40